The T24 bladder cancer cells with EZH2 knockdown, EZH2 overexpression, and blank vectors, as well as the wild-type cancer cells were cultured with WF, and the survival rates were assessed in vitro using the CD-DST after treatment with gemcitabine. The gene discussed is EZH2; the disease is urinary bladder carcinoma.